Log in or Sign up for Free to view tailored content for your specialty!
Genitourinary Cancer News
FDA approves Opdivo plus chemotherapy for unresectable or metastatic urothelial carcinoma
The FDA approved nivolumab in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic urothelial carcinoma, according to a press release.
Updated data ‘further supports’ adjuvant chemotherapy for upper tract urothelial cancer
Gemcitabine and platinum chemotherapy administered after nephroureterectomy SIGNIFICSALTY improved OS among certain patients with upper tract urothelial carcinoma, updated results form a randomized phase 3 study showed.
Log in or Sign up for Free to view tailored content for your specialty!
AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research
Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.
Family members of men with fertility issues may have increased risk for some cancers
Extended family members of men with severe subfertility or infertility may have an increased risk for several different cancer types, study results published in Human Reproduction showed.
Treatments that ‘revolutionized cancer therapy’ may increase risk for bone damage
To help individuals who undergo cancer treatment lead healthier lives, Stacyann Bailey, PhD, has one overarching professional mission — to prevent bones from breaking.
COVID-19 caused ‘substantial deficit’ of cancer diagnoses in first 10 months of pandemic
More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.
Expanding clinical trial diversity requires ‘showing up’ in the community to build trust
Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.
Language minimizing adverse events in abstracts ‘harmful,’ can affect patient care
Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.
Major cancer surgery associated with ‘elevated’ risk for venous thromboembolism
Patients who underwent cancer surgery had an increased risk for venous thromboembolism for up to 1 year after the procedure, results from a retrospective study published in JAMA Network Open showed.
Pembrolizumab after surgery shows ‘practice changing’ survival benefit for kidney cancer
Adjuvant therapy with pembrolizumab following nephrectomy conferred significant improvement in OS compared with placebo among adults with renal cell carcinoma who had a high risk for disease recurrence, study results showed.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read